GKNM Logo
/images/doctor//2025/03/dr-v-prabhu-gknm-hospital.webp

Dr. V. Prabhu

MBBS, MD(General Medicine), DM(Clinical Immunology and Rheumatology)

Consultant Clinical Immunology and Rheumatology

Dr. V. Prabhu
Dr. V. Prabhu

Awards & Achievements

  • Best Outgoing Student & Gold Medalist in Internal Medicine (Year of 2019)

Research & Publications

  • Prabhu Vasanth, Rahul Sahu et al., Pancreatitis in Lupus: all of them do not require Immunosuppression – AT Journal of Rheumatology 2023 Oct;Vol.1; Issue 1:17
  • Joseph, J., Prabhu, V., Thomas, M. et al. Myofibroblast and pro-fibrotic cytokines in fibrosis of IgG4-related disease (IgG4-RD) patients from South Asia: preliminary data. Clin Rheumatol (2024). https://doi.org/10.1007/s10067-02306861-9
  • Mixed response to tofacitinib in indian patients with refractory Takayasu arteritis: a multi-center study. Geol.R, Prabhu V, Padiyar Set al. EULAR Abstracts 2023. AB 0710. DOI: 10.1136/annrheumdis-2023-eular.5657
  • Cost-Effective Therapy In Axial Spondylarthritis: A Comparative Analysis Of Two Treatment Strategies. Prabhu Vasanth, S. Rajendran, A. Jacob Mathew, R. Goel, J. Mathew. EULAR Abstracts 2023. AB0950. DOI: 10.1136/annrheumdis-2023-eular.5901
  • Gopi Sindhuja; Prabhu, V;Mathew, AshishJ; Mathew ,John; Goel, Ruchika. Posters Abstracts. Indian Journal of Rheumatology17 (Suppl1): pS25-S203, November2022.
  • Nath S, Parmar P, Prabhu V, Garg S, Kumar S. Motor axonal neuropathy in sequence with acute transverse myelitis. Ann Trop Med Public Health 2017;10:1824-1826
  • Vasanth P, Mathew J, K D. Do CsDMARDs Still Play a Significant Role in Managing Rheumatoid Arthritis in the Current Biologic/JAKI Era? A Prospective Observational Study to Estimate the Extent of Response to Conventional Synthetic DMARDs in RA– Experience from a Tertiary Care Center in South India [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9).
  • Prabhu Vasanth, Arvind Ganapati, Banupriya G, John Mathew. Do Conventional Synthetic Dmards Still Play A Role In The Management Of Rheumatoid Arthritis In This Era Of Biologicals/Jak-Inhibitors – A Real-World Prospective Data from A Tertiary Care Center In South India. Annals of the Rheumatic Diseases 83(Suppl 1):1558.1-1558.June 2024
  • A Clinical Case Report of Deficiency of Adenosine Deaminase 2 Syndrome (DADA 2) Presenting as a Brachial Artery Aneurysm Shama Sowdagar, Prabhu Vasanth, John Mathew. Mediterranean Journal of Rheumatology Oct 2024.
  • Vasanth P, Mathew J, K D. Do CsDMARDs Still Play a Significant Role in Managing Rheumatoid Arthritis in the Current Biologic/JAKI Era? A Prospective Observational Study to Estimate the Extent of Response to Conventional Synthetic DMARDs in RA– Experience from a Tertiary Care Center in South India [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9).

New OP Days

Mon & Sat 8am-5pm

Clincal Experience

10 years

Language

Tamil, English